GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.

Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his ...

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.

Columnist Sam Kirton, calling the PF world an inclusive community, promotes care for those LGBTQIA+ while appealing to them to donate organs.

Columnist Sam Kirton compares his experiences with idiopathic pulmonary fibrosis with varied genres of film, from horror to Hallmark.

A Phase 2 clinical trial has begun recruiting that’s assessing the safety and efficacy of LTI-03, Rein Therapeutics ’ inhaled therapy for idiopathic pulmonary fibrosis (IPF).

Having identified two vertebral fractures, columnist Sam Kirton's care team orders a plethora of tests to assess his bone density.

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic pulmonary fibrosis.

Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.